Patent details

Basic Information

Publication number:

EP3431142

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181777889

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DECITABINE DERIVATIVE FORMULATIONS

French Title of Invention:

FORMULATIONS DE DÉRIVÉS DE DÉCITABINE

German Title of Invention:

DECITABINDERIVATFORMULIERUNGEN

SPC Number:

Dates

Filing date:

29/08/2012

Grant date:

17/06/2020

EP Publication Date:

23/01/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/06/2020

EP B1 Publication Date:

17/06/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/08/2020

Expiration date:

29/08/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/06/2020

 

 

Name:

Astex Pharmaceuticals, Inc.

Address:

4420 Rosewood Drive, Suite 200, Pleasanton, CA 94588, United States (US)

Inventor

1

Name:

TANG, Chunlin

Address:

United States (US)

2

Name:

REDKAR, Sanjeev

Address:

United States (US)

3

Name:

RAVIVARAPU, Harish

Address:

United States (US)

4

Name:

JOSHI-HANGAL, Rajashree

Address:

United States (US)

Priority

Priority Number:

201161529081 P

Priority Date:

30/08/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/19; A61K 31/7068; A61K 47/20; A61P 35/00; A61K 47/10;

Publication

European Patent Bulletin

Issue number:

202025

Publication date:

17/06/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages